Policy makers are increasingly tying payments for health care providers to their performance on quality measures, though there is little empirical evidence to guide the design of such incentives. I deploy administrative Medicare claims data to study a large federal program which penalizes hospitals with high rates of repeat hospitalizations (“readmissions”). I exploit the introduction of the penalty and policy-driven variation in penalty across hospitals to identify the effect of the program on hospital admission and treatment decisions, and on patient health. The program is associated with a 5% decrease in readmission accompanied by a 3% reduction in thirty day mortality. I quantify the role of two mechanisms – improvement in treatment quality and changes in admitting behavior – and find that quality improvement can explain 55-60% of the aggregate decrease. The change in admitting behavior seems driven by the penalty since there is a substantial decrease in admission rate for returning patients that could potentially incur a penalty but no such effect for those that will not. It plays a quantitatively important role and I find suggestive evidence of harm to affected patients.

More on this topic

BFI Working Paper·Mar 27, 2025

The Value of Medical Innovation in the Fight Against COVID-19 in the United States

Tomas Philipson, A. Mark Fendrick, Yier Ling, Eric Sun, and James Williams
Topics: Health care
BFI Working Paper·Mar 10, 2025

The Rise of Healthcare Jobs

Joshua Gottlieb, Neale Mahoney, Kevin Rinz, and Victoria Udalova
Topics: Employment & Wages, Health care
BFI Working Paper·Feb 18, 2025

Economic Shocks and Healthcare Capital Investments

Michael R. Richards, Maggie Shi, and Christopher M. Whaley
Topics: Health care